title: Correlates of participation in AIDS education and HIV antibody testing by methadone patients.
abstract: The authors examined the factors associated with methadone patients' decisions about participating in a clinic-based AIDS prevention protocol. Despite the offer of incentives, only 27 percent attended AIDS education and only 12 percent obtained voluntary HIV antibody (ab) testing. However, AIDS education was attended by proportionately more of those who were at highest risk for AIDS because of current intravenous drug use. The availability of HIV-ab testing neither encouraged nor discouraged participation in AIDS education. Patients who were relatively more likely to choose HIV-ab testing were older, had been or were married, had plans to have children, believed the test to be useful, and believed that their counselors support their decision to be tested. Those who declined to be tested were reluctant to confront the emotional aspects of their risk status, were concerned about possible breaches of confidentiality, and doubted the value of testing. The implications of the findings for implementing AIDS prevention measures in methadone programs are discussed. Programs need either to require attendance at AIDS education or give patients an incentive to attend. HIV-ab testing should be available but should remain voluntary. A stronger medical rationale for testing is developing and may increase future participation. Methadone programs must continue to engage patients actively in AIDS risk reduction efforts.
authors.affiliation: Narcotic and Drug Research, Inc., New York, NY 10013.
authors.forename: S
authors.initials: S
authors.lastname: Magura
authors.forename: J I
authors.initials: JI
authors.lastname: Grossman
authors.forename: D S
authors.initials: DS
authors.lastname: Lipton
authors.forename: K R
authors.initials: KR
authors.lastname: Amann
authors.forename: J
authors.initials: J
authors.lastname: Koger
authors.forename: K
authors.initials: K
authors.lastname: Gehan
mesh_terms: D015492:AIDS Serodiagnosis / Q000523:psychology*; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D000328:Adult; D005260:Female; D006266:Health Education; D006556:Heroin Dependence / Q000534:rehabilitation*; D006746:Hospital Bed Capacity, 500 and over; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009519:New York City; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D012307:Risk Factors
chemical_list: D008691:Methadone